Kamada says it did not capitalize pre-approval inventory costs in 2025 or 2024 after SEC query
KMDA•Kamada told the SEC it did not capitalize costs for inventory produced for commercial sale before regulatory approval in 2025 or 2024. It plans to expand future disclosures about its accounting assessment and any material pre-approval costs capitalized.
1. SEC response
Kamada responded to an SEC comment letter on its 2025 Form 20-F, clarifying that it did not capitalize costs for inventory produced for commercial sale before regulatory approval in 2025 or 2024. Future filings will provide more detail on how the company assesses “probable future economic benefit,” when regulatory or technical feasibility is established, and the types of pre-approval costs capitalized if material.
